199 related articles for article (PubMed ID: 27797380)
1. DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.
Fan H; Cui Z; Zhang H; Mani SK; Diab A; Lefrancois L; Fares N; Merle P; Andrisani O
Oncogene; 2017 Apr; 36(17):2435-2445. PubMed ID: 27797380
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.
Fan H; Zhang H; Pascuzzi PE; Andrisani O
Oncogene; 2016 Feb; 35(6):715-26. PubMed ID: 25893293
[TBL] [Abstract][Full Text] [Related]
3. miR-296-5p suppresses stem cell potency of hepatocellular carcinoma cells via regulating Brg1/Sall4 axis.
Shi DM; Shi XL; Xing KL; Zhou HX; Lu LL; Wu WZ
Cell Signal; 2020 Aug; 72():109650. PubMed ID: 32320856
[TBL] [Abstract][Full Text] [Related]
4. Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinoma.
Mani SKK; Yan B; Cui Z; Sun J; Utturkar S; Foca A; Fares N; Durantel D; Lanman N; Merle P; Kazemian M; Andrisani O
Theranostics; 2020; 10(24):10957-10972. PubMed ID: 33042264
[No Abstract] [Full Text] [Related]
5. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z
J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
Sze KM; Ho DW; Chiu YT; Tsui YM; Chan LK; Lee JM; Chok KS; Chan AC; Tang CN; Tang VW; Lo IL; Yau DT; Cheung TT; Ng IO
Hepatology; 2021 Jan; 73(1):23-40. PubMed ID: 32170761
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
8. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway.
Qin X; Li C; Guo T; Chen J; Wang HT; Wang YT; Xiao YS; Li J; Liu P; Liu ZS; Liu QY
J Exp Clin Cancer Res; 2017 Oct; 36(1):148. PubMed ID: 29052520
[TBL] [Abstract][Full Text] [Related]
10. Krüppel-like factor 15 activates hepatitis B virus gene expression and replication.
Zhou J; Tan T; Tian Y; Zheng B; Ou JH; Huang EJ; Yen TS
Hepatology; 2011 Jul; 54(1):109-21. PubMed ID: 21503941
[TBL] [Abstract][Full Text] [Related]
11. DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling.
Hu ZG; Zhang S; Chen YB; Cao W; Zhou ZY; Zhang JN; Gao G; He SQ
Life Sci; 2020 Oct; 258():118029. PubMed ID: 32619495
[TBL] [Abstract][Full Text] [Related]
12. Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.
Studach LL; Menne S; Cairo S; Buendia MA; Hullinger RL; Lefrançois L; Merle P; Andrisani OM
Hepatology; 2012 Oct; 56(4):1240-51. PubMed ID: 22505317
[TBL] [Abstract][Full Text] [Related]
13. Short hairpin RNA induces methylation of hepatitis B virus covalently closed circular DNA in human hepatoma cells.
Park HK; Min BY; Kim NY; Jang ES; Shin CM; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH; Kim JW
Biochem Biophys Res Commun; 2013 Jun; 436(2):152-5. PubMed ID: 23727428
[TBL] [Abstract][Full Text] [Related]
14. Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression.
Chang TS; Wu YC; Chi CC; Su WC; Chang PJ; Lee KF; Tung TH; Wang J; Liu JJ; Tung SY; Kuo LM; Ho HN; Ling TY; Huang YH
Clin Cancer Res; 2015 Jan; 21(1):201-10. PubMed ID: 25564572
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
16. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.
Xie J; Zhang Y; Zhang Q; Han Y; Yin J; Pu R; Shen Q; Lu W; Du Y; Zhao J; Han X; Zhang H; Cao G
Hepatology; 2013 Jun; 57(6):2369-77. PubMed ID: 23386590
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication.
Hösel M; Quasdorff M; Ringelhan M; Kashkar H; Debey-Pascher S; Sprinzl MF; Bockmann JH; Arzberger S; Webb D; von Olshausen G; Weber A; Schultze JL; Büning H; Heikenwalder M; Protzer U
Cell Mol Gastroenterol Hepatol; 2017 Nov; 4(3):339-363. PubMed ID: 28884137
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
[TBL] [Abstract][Full Text] [Related]
20. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
